JP2001500506A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001500506A5 JP2001500506A5 JP1998513761A JP51376198A JP2001500506A5 JP 2001500506 A5 JP2001500506 A5 JP 2001500506A5 JP 1998513761 A JP1998513761 A JP 1998513761A JP 51376198 A JP51376198 A JP 51376198A JP 2001500506 A5 JP2001500506 A5 JP 2001500506A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71370596A | 1996-09-13 | 1996-09-13 | |
| US08/713,705 | 1996-09-13 | ||
| PCT/US1997/015902 WO1998011097A1 (en) | 1996-09-13 | 1997-09-11 | Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001500506A JP2001500506A (ja) | 2001-01-16 |
| JP2001500506A5 true JP2001500506A5 (enExample) | 2005-05-12 |
Family
ID=24867191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10513761A Ceased JP2001500506A (ja) | 1996-09-13 | 1997-09-11 | ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な置換ベンゾシクロヘプタピリジン |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0931077B1 (enExample) |
| JP (1) | JP2001500506A (enExample) |
| KR (1) | KR20000036102A (enExample) |
| CN (1) | CN1104428C (enExample) |
| AT (1) | ATE294172T1 (enExample) |
| AU (1) | AU4337597A (enExample) |
| CA (1) | CA2264666A1 (enExample) |
| DE (1) | DE69733142T2 (enExample) |
| ES (1) | ES2242232T3 (enExample) |
| HU (1) | HUP0000073A3 (enExample) |
| IL (1) | IL128926A0 (enExample) |
| NZ (1) | NZ334341A (enExample) |
| WO (1) | WO1998011097A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| CN1289336A (zh) | 1998-01-21 | 2001-03-28 | 千禧药品公司 | 趋化因子受体拮抗剂和其使用方法 |
| EP1047675A1 (en) | 1998-01-21 | 2000-11-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6288083B1 (en) | 1998-09-04 | 2001-09-11 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US6503926B2 (en) | 1998-09-04 | 2003-01-07 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| US7417026B2 (en) | 2003-08-13 | 2008-08-26 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
| HRP20110804T1 (hr) | 2005-06-23 | 2011-11-30 | Merck Sharp & Dohme Corp. | Benzocikloheptapiridini kao inhibitori receptora tirozin kinaze met |
| TW200813021A (en) | 2006-07-10 | 2008-03-16 | Merck & Co Inc | Tyrosine kinase inhibitors |
| US7935715B2 (en) | 2006-07-28 | 2011-05-03 | Boehringer Ingelheim International Gmbh | Compounds which modulate the CB2 receptor |
| WO2009061652A1 (en) | 2007-11-07 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| WO2010005782A1 (en) | 2008-07-10 | 2010-01-14 | Boehringer Ingelheim International Gmbh | Sulfone compounds which modulate the cb2 receptor |
| KR20110063438A (ko) | 2008-09-25 | 2011-06-10 | 베링거 인겔하임 인터내셔날 게엠베하 | Ｃｂ2 수용체를 선택적으로 조절하는 설포닐 화합물 |
| WO2010096371A2 (en) | 2009-02-18 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the cb2 receptor |
| US8299103B2 (en) | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| WO2010147791A1 (en) * | 2009-06-16 | 2010-12-23 | Boehringer Ingelheim International Gmbh | Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor |
| US8383651B2 (en) | 2009-09-22 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| JP2013517271A (ja) | 2010-01-15 | 2013-05-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を調節する化合物 |
| WO2011109324A1 (en) | 2010-03-05 | 2011-09-09 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the cb2 receptor |
| JP5746764B2 (ja) | 2010-07-22 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を調節する化合物 |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1593417A (en) * | 1976-12-22 | 1981-07-15 | Squibb & Sons Inc | Carbocyclic-fused pyrazolopyridine derivatives |
| US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| IE68935B1 (en) * | 1990-06-22 | 1996-07-24 | Schering Corp | Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| ATE210652T1 (de) * | 1993-10-15 | 2001-12-15 | Schering Corp | Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen |
-
1997
- 1997-09-11 KR KR1019997002121A patent/KR20000036102A/ko not_active Withdrawn
- 1997-09-11 EP EP97941476A patent/EP0931077B1/en not_active Expired - Lifetime
- 1997-09-11 CN CN97199528A patent/CN1104428C/zh not_active Expired - Fee Related
- 1997-09-11 AU AU43375/97A patent/AU4337597A/en not_active Abandoned
- 1997-09-11 WO PCT/US1997/015902 patent/WO1998011097A1/en not_active Ceased
- 1997-09-11 AT AT97941476T patent/ATE294172T1/de not_active IP Right Cessation
- 1997-09-11 JP JP10513761A patent/JP2001500506A/ja not_active Ceased
- 1997-09-11 IL IL12892697A patent/IL128926A0/xx unknown
- 1997-09-11 CA CA002264666A patent/CA2264666A1/en not_active Abandoned
- 1997-09-11 HU HU0000073A patent/HUP0000073A3/hu unknown
- 1997-09-11 ES ES97941476T patent/ES2242232T3/es not_active Expired - Lifetime
- 1997-09-11 NZ NZ334341A patent/NZ334341A/xx unknown
- 1997-09-11 DE DE69733142T patent/DE69733142T2/de not_active Expired - Fee Related